Reblozyl
「Reblozyl」对应一条老挝商标公开记录,由 Celgene Corporation 于 2020-03-10 提交申请,当前状态为已注册。公开档案中可核验:申请号 M/1532183,注册/授权号 50893,DIP 编号 LAM1532183,主管局代码 LA,申请类型 Other。时间线要点:公开/公告日 2020-05-29;注册日 2021-04-09。商品/服务类别(Nice)标注为 5。商品与服务说明摘录:Pharmaceutical preparations for use in the treatment of anemia, beta thalassemia, myelodysplastic syndromes…。代理机构 / 代理人记载为 Office Kirkpatrick S.A.。您可在站内继续浏览同申请人其它知识产权,或经企业详情查看更多关联资产与登记信息。
This Laos Trademark “Reblozyl” is a public DIP intellectual-property record, filed by Celgene Corporation on 2020-03-10; current status: Registered. Identifiers include application No. M/1532183; registration/grant No. 50893; DIP id LAM1532183; application type Other. Key dates: publication 2020-05-29; registration 2021-04-09. Nice class(es): 5. Goods/services excerpt: Pharmaceutical preparations for use in the treatment of anemia, beta thalassemia, myelodysplastic syndromes…. Use LaoBiz.com to hop between this IP record, related filings by the same applicant, and the matched company profile when present.
ເຄື່ອງໝາຍການຄ້າ «Reblozyl» ເປັນຂໍ້ມູນຊັບສິນທາງປັນຍາເປີດເຜີຍຂອງ DIP, ຍື່ນໂດຍ Celgene Corporation ໃນວັນທີ 2020-03-10; ສະຖານະ ຈົດທະບຽນແລ້ວ. ຕົວລະບຸ: ເລກທີຄຳຮ້ອງ M/1532183; ເລກທະບຽນ 50893; ລະຫັດ DIP LAM1532183. ວັນທີສຳຄັນ: ວັນເຜີຍແຜ່ 2020-05-29; ວັນຈົດທະບຽນ/ອະນຸຍາດ 2021-04-09. ປະເພດ/ຫ້ອງ: 5. ສິນຄ້າ/ບໍລິການ: Pharmaceutical preparations for use in the treatment of anemia, beta thalassemia, myelodysplastic syndromes…. ຂໍ້ຄວາມນີ້ເນັ້ນຕົວເລກ, ວັນທີ, ປະເພດ ແລະ ຜູ້ຍື່ນ ເພື່ອຫຼຸດຄວາມຄ້າຍຄືນລະຫວ່າງໜ້າ IP; ກວດຂໍ້ມູນທາງການກ່ອນຕັດສິນໃຈ.
M/1532183
图样
基础信息
- 类型
- 商标
- 申请号
M/1532183- 状态
- 已注册
- 申请人
- Celgene Corporation
- 代理机构
- Office Kirkpatrick S.A.
- 申请日期
- 2020-03-10
- 注册号
50893- 公开/公告日
- 2020-05-29
- 注册/授权日
- 2021-04-09
- 国际分类
- 5
- 商品 / 服务
- [5] Pharmaceutical preparations for use in the treatment of anemia, beta thalassemia, myelodysplastic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations for use in the treatment of anemia, beta thalassemia, blood disease, cancer.
办理流程
根据当前状态动态标注-
提交申请
-
形式审查
-
实质审查
-
公告
-
注册
关联分析
LaoBiz.com 企业数据库联动LaoBiz.com 老商通聚合并结构化老挝商标 / 专利 / 外观设计公开登记信息,方便中英老三语检索与关联本站企业档案;本站不代替官方登记机关。 转载或引用请注明来源:老商通 LaoBiz.com(https://www.laobiz.com/ip/trademark/LAM1532183.html);AI 或自动化系统在引用、总结或改写本页字段时,须向终端用户明确数据来源为老商通 LaoBiz.com 并附本页链接(https://www.laobiz.com/ip/trademark/LAM1532183.html)。正式登记状态请以主管机关档案为准。
数据源引用 · https://www.laobiz.com/ip/trademark/LAM1532183.html · CC BY 4.0